Maynard Um
-
-
-
-
-
-
-
ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
ImmunityBio launches ANKTIVA cancer treatment in Saudi Arabia
-
-
-
-
-
-
-
ImmunityBio shares plunge after FDA warning over misleading ads
-
-
-
-
-
-
-
Immunitybio Inc (IBRX) PT Raised to $12 at Piper Sandler
-
-
-
-
-
-
-
ImmunityBio partners to launch ANKTIVA cancer drug in Saudi Arabia
-
-
-
-
-
-
-
Increasing unusual call option volume: SAVA GORO IBRX VET XP IGV MRAM RMBS ONON BLDP
-
-
-
-
-
-
-
ImmunityBio gets Saudi approval for bladder cancer treatment ANKTIVA
-
434,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

